MedTrace Logo

Influenza Challenge Study of VIS410 in Healthy Volunteers

NCT02468115 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2016-04-05

No results posted yet for this study

Summary

A phase 2 a study to assess the safety profile and the effect of VIS410 in healthy subjects after inoculation with influenza A virus (H1N1).

Conditions

Interventions

DRUG

VIS410

Single fixed IV dose of VIS410

DRUG

Placebo

Single IV dose of placebo

Sponsors & Collaborators

  • Visterra, Inc.

    lead INDUSTRY

Principal Investigators

  • M Petkova · SGS Life Sciences, a division of SGS Belgium NV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02468115 on ClinicalTrials.gov